BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 35657974)

  • 1. Selective Activation of M
    Sundel MH; Sampaio Moura N; Cheng K; Chatain O; Hu S; Drachenberg CB; Xie G; Raufman JP
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-point immobilization of M3 muscarinic receptor: a method for recognizing receptor antagonists in natural products.
    Huang X; Wang T; Wang L; Sun Y; Zhang Z; Zhang Y
    BMC Chem; 2024 May; 18(1):94. PubMed ID: 38702791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic Mechanisms in Gastrointestinal Neoplasia.
    Sampaio Moura N; Schledwitz A; Alizadeh M; Kodan A; Njei LP; Raufman JP
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine, Another Factor in Breast Cancer.
    Muñoz JP; Calaf GM
    Biology (Basel); 2023 Nov; 12(11):. PubMed ID: 37998017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diagnostic and Prognostic Value of Neurotransmitter Receptor-Related Genes in Colon Adenocarcinoma.
    Hu J; Wu Y; Dong X; Zeng Y; Wang Y
    Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37833465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.
    Felton J; Hu S; Raufman JP
    Curr Mol Pharmacol; 2018; 11(3):184-190. PubMed ID: 29357811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer.
    Ali O; Tolaymat M; Hu S; Xie G; Raufman JP
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic receptor activation in colon cancer selectively augments pro-proliferative microRNA-21, microRNA-221 and microRNA-222 expression.
    Larabee SM; Cheng K; Raufman JP; Hu S
    PLoS One; 2022; 17(6):e0269618. PubMed ID: 35657974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
    Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP
    Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation.
    Cheng K; Samimi R; Xie G; Shant J; Drachenberg C; Wade M; Davis RJ; Nomikos G; Raufman JP
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G591-7. PubMed ID: 18653726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells.
    Cheng K; Zimniak P; Raufman JP
    Cancer Res; 2003 Oct; 63(20):6744-50. PubMed ID: 14583469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells.
    Xie G; Cheng K; Shant J; Raufman JP
    Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G755-63. PubMed ID: 19221016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine stimulates cortical precursor cell proliferation in vitro via muscarinic receptor activation and MAP kinase phosphorylation.
    Ma W; Maric D; Li BS; Hu Q; Andreadis JD; Grant GM; Liu QY; Shaffer KM; Chang YH; Zhang L; Pancrazio JJ; Pant HC; Stenger DA; Barker JL
    Eur J Neurosci; 2000 Apr; 12(4):1227-40. PubMed ID: 10762352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Actions of Muscarinic Receptor Subtypes in Gastric, Pancreatic, and Colon Cancer.
    Schledwitz A; Sundel MH; Alizadeh M; Hu S; Xie G; Raufman JP
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Role for Combined Subtype-Selective Targeting of M
    Tolaymat M; Sundel MH; Alizadeh M; Xie G; Raufman JP
    Front Pharmacol; 2021; 12():786105. PubMed ID: 34803723
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.